Inflammatory Skin Disease
Dermapharm AG’s clinical research activity includes studies in chronic stable plaque psoriasis and atopic dermatitis, with a focus on topical treatments for persistent dermatological inflammation and skin barrier impairment.
- Plaque psoriasis
- Atopic dermatitis
- Topical corticosteroid therapy
Its research portfolio in this area centers on ointment and cream formulations intended for common chronic inflammatory skin conditions.
Acne and Rosacea
The sponsor also funds research in papulopustular acne and papulopustular rosacea, reflecting a therapeutic interest in facial inflammatory disorders marked by papules, pustules, and persistent erythema.
- Papulopustular acne
- Papulopustular rosacea
- Facial inflammatory lesions
These studies involve topical anti-inflammatory and antimicrobial dermatologic treatments.
Cutaneous Fungal Infection
Dermapharm AG has active research in moderately to severely inflamed candidiasis of the skin, addressing fungal skin infection with associated inflammation and irritation.
- Candidiasis of the skin
- Antifungal therapy
- Inflammation control
The sponsor’s work in this field includes evaluation of combined antifungal and anti-inflammatory topical agents.
Topical Dermatologic Formulations
A recurring theme across the sponsor’s trial portfolio is the development of topical formulations for skin disease, including cream, ointment, and gel products used in localized treatment.
- Cream formulations
- Ointment formulations
- Gel formulations
These studies reflect interest in delivery systems for corticosteroids, antifungals, antibiotics, and other dermatologic active substances.
Comparative Dermatology Research
The clinical program includes comparative evaluation of reference products, vehicle controls, and sponsor-developed topical medicines in common skin disorders.
- Reference medicine comparisons
- Vehicle-controlled dermatology studies
- Inflammatory lesion reduction
This research activity spans a range of dermatological therapeutic areas managed through the company’s Department of Clinical Research in Germany.
